Genomics Research Analysis Platform

NHSBT currently undertakes genetic testing for a variety of diagnostic purposes. This includes the use of sequence-based typing methods (both NGS and Sanger sequencing) for approx. 120-150,000 tests/yr. and real time-PCR, PCR-SSP and PCR-SSO for approx. 200,000 tests/yr.

Since 2021 the Genomics programme has been initiating several subsidiary projects focussing on the use of two different types of technology.

Delivery of the Genomics programme is identified as a key driver within NHSBT's business plan, significantly contributing to 4 of the 5 strategic pillars:

NHSBT is looking for one supplier to deliver the following aims:

At this stage NHSBT is looking for suppliers who may be interested in a potential future competition, demonstrating their potential solution or informing our business case. Potential suppliers can respond to this RFI by completing the Response Section. If this opportunity is not suitable for your organisation, there is no need to respond. Suppliers who respond positively will be added to a mailing list and may be invited to a virtual information-gathering session with key stakeholders. At any point suppliers are welcome to remove themselves from further communication at any point should they wish.

Additional information:

To express interest and participate in a potential procurement process, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome

Should interested parties have any queries, or have problems using the portal, they should contact Helpdesk at:

Phone: 0800 9956035

Email: support-health@atamis.co.uk